These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2224118)

  • 1. Bleeding complications associated with cardiopulmonary bypass.
    Woodman RC; Harker LA
    Blood; 1990 Nov; 76(9):1680-97. PubMed ID: 2224118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of hemostasis associated with cardiopulmonary bypass: pathophysiology, prevention, diagnosis, and management.
    Bick RL
    Semin Thromb Hemost; 1976 Oct; 3(2):59-82. PubMed ID: 798278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass.
    Guzzetta NA; Allen NN; Wilson EC; Foster GS; Ehrlich AC; Miller BE
    Anesth Analg; 2015 Feb; 120(2):405-10. PubMed ID: 25390280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.
    Flaujac C; Pouard P; Boutouyrie P; Emmerich J; Bachelot-Loza C; Lasne D
    Thromb Haemost; 2007 Aug; 98(2):385-91. PubMed ID: 17721621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin restores the adhesive capacity of dysfunctional platelets.
    Bradfield JF; Bode AP
    Thromb Res; 2003 Feb; 109(4):181-8. PubMed ID: 12757772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
    Ray MJ; Marsh NA; Hawson GA
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of bleeding complications in redo cardiac operations.
    Smith CR
    Ann Thorac Surg; 1998 Apr; 65(4 Suppl):S2-8; discussion S27-8. PubMed ID: 9563396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery.
    Rocha E; Hidalgo F; Llorens R; Melero JM; Arroyo JL; Páramo JA
    Circulation; 1994 Aug; 90(2):921-7. PubMed ID: 7519132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery.
    Emeklibas N; Kammerer I; Bach J; Sack FU; Hellstern P
    Transfusion; 2013 Jun; 53(6):1226-34. PubMed ID: 22934739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization.
    Mongan PD; Brown RS; Thwaites BK
    Anesth Analg; 1998 Aug; 87(2):258-65. PubMed ID: 9706913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose aprotinin is ineffective to treat excessive bleeding after cardiopulmonary bypass.
    Forestier F; Bélisle S; Robitaille D; Martineau R; Perrault LP; Hardy JF
    Ann Thorac Surg; 2000 Feb; 69(2):452-6. PubMed ID: 10735680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet Function Changes during Neonatal Cardiopulmonary Bypass Surgery: Mechanistic Basis and Lack of Correlation with Excessive Bleeding.
    Zwifelhofer NMJ; Bercovitz RS; Cole R; Yan K; Simpson PM; Moroi A; Newman PJ; Niebler RA; Scott JP; Stuth EAD; Woods RK; Benson DW; Newman DK
    Thromb Haemost; 2020 Jan; 120(1):94-106. PubMed ID: 31752040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.
    Davis R; Whittington R
    Drugs; 1995 Jun; 49(6):954-83. PubMed ID: 7543841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding.
    Gelb AB; Roth RI; Levin J; London MJ; Noall RA; Hauck WW; Cloutier M; Verrier E; Mangano DT
    Am J Clin Pathol; 1996 Jul; 106(1):87-99. PubMed ID: 8701939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin.
    Czer LS; Bateman TM; Gray RJ; Raymond M; Stewart ME; Lee S; Goldfinger D; Chaux A; Matloff JM
    J Am Coll Cardiol; 1987 May; 9(5):1139-47. PubMed ID: 3571753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion and bleeding in coronary artery bypass grafting: an on-pump versus off-pump comparison.
    Potger KC; McMillan D; Southwell J; Connolly T; Smith KK; Ambrose M
    J Extra Corpor Technol; 2007 Mar; 39(1):24-30. PubMed ID: 17486870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
    Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
    Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.